Evidence map›Paper›PMID 20711470›Full record

ArticlePloS one2010

TLR4 Asp299Gly and Thr399Ile polymorphisms: no impact on human immune responsiveness to LPS or respiratory syncytial virus.

Renée N Douville, Yuriy Lissitsyn, Aaron F Hirschfeld, Allan B Becker, Anita L Kozyrskyj, Joel Liem, Nathalie Bastien, Yan Li, Rachel E Victor, Mehtab Sekhon and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. ERVK activity in CD8Journal of neuroinflammation · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Genes · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Respiratory syncytial virus--a comprehensive review.Clinical reviews in allergy & immunology · 2013
    Review
  18. Article
  19. Coding variants of TLR2 and TLR4 genes do not substantially contribute to prosthetic joint infection.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2013
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Renée N DouvilleCIHR National Training Program in Allergy and Asthma Research, Department of Immunology, University of Manitoba, Winnipeg, Canada.
Yuriy Lissitsyn
Aaron F Hirschfeld
Allan B Becker
Anita L Kozyrskyj
Joel Liem
Nathalie Bastien
Yan Li
Rachel E Victor
Mehtab Sekhon
Stuart E Turvey
Kent T HayGlass
University of Manitoba · CAChild and Family Research Institute · CABC Children's Hospital · CACanadian Science Centre for Human and Animal Health · CA

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

backgroundA broad variety of natural environmental stimuli, genotypic influences and timing all contribute to expression of protective versus maladaptive immune responses and the resulting clinical outcomes in humans. The role of commonly co-segregating Toll-like receptor 4 (TLR4) non-synonymous single nucleotide polymorphisms Asp299Gly and Thr399Ile in this process remains highly controversial. Moreover, what differential impact these polymorphisms might have in at risk populations with respiratory dysfunction, such as current asthma or a history of infantile bronchiolitis, has never been examined. Here we determine the importance of these polymorphisms in modulating LPS and respiratory syncytial virus (RSV)--driven cytokine responses. We focus on both healthy children and those with clinically relevant respiratory dysfunction. METHODOLOGY: To elucidate the impact of TLR4 Asp299Gly and Thr399Ile on cytokine production, we assessed multiple immune parameters in over 200 pediatric subjects aged 7-9. Genotyping was followed by quantification of pro- and anti-inflammatory cytokine responses by fresh peripheral blood mononuclear cells upon acute exposure to LPS or RSV. PRINCIPAL

findingsIn contrast to early reports, neither SNP influenced immune responses evoked by LPS exposure or RSV infection, as measured by the intermediate phenotype of pro- and anti-inflammatory cytokine responses to these ubiquitous agents. There is no evidence of altered sensitivity in populations with "at risk" clinical phenotypes. CONCLUSIONS/SIGNIFICANCE: Genomic medicine seeks to inform clinical practice. Determination of the TLR4 Asp299Gly/Thr399Ile haplotype is of no clinical benefit in predicting the nature or intensity of cytokine production in children whether currently healthy or among specific at-risk groups characterized by prior infantile broncholitis or current asthma.

Indexed as

AsthmaBronchiolitisChildCytokinesHaplotypesHumansImmunityLipopolysaccharidesPolymorphism, Single NucleotideRespiratory Syncytial VirusesToll-Like Receptor 4CytokinesLipopolysaccharidesTLR4 protein, humanToll-Like Receptor 4

Identifiers

PMID20711470
PMCPMC2919413
OpenAlexW2106910647

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.